|Phase of Study:||Phase II|
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||No hospitalization required.|
|Return Visit:||Daily for 5 days, then weekly for 8 weeks then every three months for first |
year. Patients can receive their treatment locally after the first dose of both
agents has been administered at M.D. Anderson.
|Home Care:||Patients can receive their 2CDA and Rituximab treatment locally after the first |
dose of both agents has been administered at M.D. Anderson.